BMI vs body fat percentage

You can deadlift twice your bodyweight and still be labelled obese on paper. Here's what BMI misses, and where body fat percentage takes the measurement deeper.

The battle of the metrics

Step on any set of scales and you get a number. Plug that into the body mass index (BMI) formula - weight in kilograms divided by height in metres squared - and you get another. That's the metric the NHS, the National Institute for Health and Care Excellence (NICE), and the World Health Organization still use as their first-line screen for weight-related health risk.¹

Body fat percentage is a different question entirely. Rather than a weight-to-height ratio, it's the proportion of your total mass that's actually fat - the "under the hood" read of your physical composition.²

Both numbers matter. They're just answering different questions, and using them interchangeably is how muscular, trained individuals end up miscategorised as obese on paper.³ If you already suspect BMI is failing you, our guide to BMI's limitations is the place to start.

Body mass index (BMI): the clinical standard

BMI is the most widely used weight screening tool in the world- accessible, easy to calculate, and a useful starting point. Like any single number, though, it has its strengths and its limits.⁴

Pros

1. Fast, free, and non-invasive. You need nothing more than scales and a tape measure.

2. Backed by decades of global epidemiological data linking BMI ranges to diabetes, cardiovascular disease, and all-cause mortality.⁵

3. Reproducible. Two clinicians working independently arrive at the same number.

4. In the UK, BMI is the primary entry point for NICE-recommended weight management pathways, including eligibility for pharmacological treatment.⁶

Cons

1. Cannot distinguish between fat, muscle, bone, or water. Two people with identical BMIs can have very different body compositions.⁷

2. Ignores where fat is stored. Visceral fat (around the organs) carries far greater metabolic risk than subcutaneous fat (under the skin), but BMI is blind to the distinction.⁸

3. Standard thresholds were largely derived from white European populations, and underestimate risk in South Asian, Black, Chinese, and Arab groups.⁹

BMI is best understood as a population-level proxy. Useful at scale, less reliable up close. For flagging general risk categories (overweight, obesity) where closer clinical assessment may be warranted, it remains the appropriate first step. NICE continues to use BMI as the gatekeeping metric for weight management interventions, including semaglutide and tirzepatide.¹⁰,¹¹

Body fat percentage: the composition deep dive

Body fat percentage answers the question BMI can't: how much of you is actually fat?

Pros

1. Differentiates lean mass (muscle, bone, organs) from adipose tissue - the single biggest blind spot in BMI.⁷

2. Far more accurate for athletic populations. In a study of prospective NFL athletes at the Scouting Combine, BMI classified 53.4% as obese. When measured directly via air-displacement plethysmography, the real rate was 8.9%.³

3. Tracks the quality of weight change. Body fat percentage reveals whether the scales are falling because you're losing fat, losing muscle, or shedding water - a distinction BMI cannot make.

4. Correlates more tightly with cardiometabolic risk than weight-based metrics alone, especially when combined with information about fat distribution.⁸

Cons

1. Harder to measure accurately. There's a range of options- from simple skinfold calipers (cheap, but accuracy depends on the person measuring) and at-home bioimpedance devices (easy to use, but readings can fluctuate) to DEXA scans and the BOD POD, which give the most accurate results but need specialist kit.

2. Single measurements are sensitive to hydration, recent meals, and time of day. BIA readings in particular can swing several percentage points between sessions.

3. No universally agreed "healthy" thresholds. Ranges vary by sex, age, ethnicity, and athletic population.

4. Not currently used by the NHS as a clinical gatekeeper for weight management treatment. BMI remains the eligibility metric.⁶

Body fat percentage is the more useful number for anyone trying to lose fat while building or holding onto muscle, athletes whose BMI looks high simply because they carry a lot of muscle, and anyone wondering whether a "healthy" BMI might be masking hidden fat around their organs. This is sometimes called the TOFI profile: thin outside, fat inside.⁸ Where BMI puts you in a box, body fat percentage tells you what's actually in it.

Key facts: BMI vs body fat at a glance

Which metric to use?

The honest answer: probably both.

For general health screening

BMI remains the most practical and accessible starting point. It's cheap, repeatable, and the metric UK weight management pathways are built around.⁶ If you're trying to work out whether you qualify for clinical support, BMI – not body fat percentage – is what sets the threshold, though the specific cut-off depends on the treatment, any coexisting conditions, and ethnicity.⁶,⁹,¹⁰,¹¹

For fitness and performance

Body fat percentage may provide a more detailed view of body composition when tracking the quality of weight change. If you're training with the aim of body recomposition - losing fat while building muscle - the scales and BMI will often barely move while your composition shifts significantly. DEXA is the gold standard. BIA and calipers, measured consistently under the same conditions, are practical alternatives.

The numan take

No single number captures individual health. Use BMI as a first-pass risk categorisation, body fat percentage to understand composition, and waist circumference (or waist-to-height ratio) to flag fat distribution. That trio catches far more than any one metric alone. And where it still falls short, bloodwork fills the gap. BMI is a population-level proxy, not a personal verdict.

References

1. Wu Y, Li D, Vermund SH. Advantages and limitations of the body mass index (BMI) to assess adult obesity. Int J Environ Res Public Health. 2024;21(6):757.

2. Sweatt K, Garvey WT, Martins C. Strengths and limitations of BMI in the diagnosis of obesity: what is the path forward? Curr Obes Rep. 2024;13(3):584–595.

3. Provencher MT, Chahla J, Sanchez G, Cinque ME, Kennedy NI, Whalen J, et al. Body mass index versus body fat percentage in prospective National Football League athletes: overestimation of obesity rate in athletes at the National Football League Scouting Combine. J Strength Cond Res. 2018;32(4):1013–1019.

4. Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015;50(3):117–128.

5. Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944–953.

6. National Institute for Health and Care Excellence. Overweight and obesity management [NG246]. London: NICE; 2023.

7. Gonzalez MC, Correia MITD, Heymsfield SB. A requiem for BMI in the clinical setting. Curr Opin Clin Nutr Metab Care. 2017;20(5):314–321.

8. Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715–725.

9. Caleyachetty R, Barber TM, Mohammed NI, Cappuccio FP, Hardy R, Mathur R, et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2021;9(7):419–426.

10. National Institute for Health and Care Excellence. Semaglutide for managing overweight and obesity [TA875]. London: NICE; 2023.

11. National Institute for Health and Care Excellence. Tirzepatide for managing overweight and obesity [TA1026]. London: NICE; 2024.